טוען...
Drugs in early clinical development for Systemic Lupus Erythematosus
INTRODUCTION: While immunosuppressive therapy has positively impacted the prognosis of systemic lupus erythematosus (SLE), many patients still do not respond to traditional therapy. Thus, active SLE disease remains a significant problem. Furthermore, conventional immunosuppressive treatments for SLE...
שמור ב:
| הוצא לאור ב: | Expert Opin Investig Drugs |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5056793/ https://ncbi.nlm.nih.gov/pubmed/26950689 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543784.2016.1162291 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|